Skip to main content

CORRECTION article

Front. Oncol., 12 August 2022
Sec. Pharmacology of Anti-Cancer Drugs
Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.989283

Corrigendum: Cucurbitacin B, purified and characterized from the rhizome of Corallocarpus epigaeus exhibits anti-melanoma potential

This article is a correction to:

  1. Cucurbitacin B, Purified and Characterized From the Rhizome of Corallocarpus epigaeus Exhibits Anti-Melanoma Potential

    1. Read original article
Sreekumar Usha Devi Aiswarya,Sreekumar Usha Devi Aiswarya1,2Gowda VikasGowda Vikas3Nair Hariprasad HarithaNair Hariprasad Haritha2Vijayasteltar Belsamma Liju,Vijayasteltar Belsamma Liju2,4Anwar ShabnaAnwar Shabna2Mundanattu SwethaMundanattu Swetha2Tennyson Prakash RayginiaTennyson Prakash Rayginia2Chenicheri Kizhakkeveettil KeerthanaChenicheri Kizhakkeveettil Keerthana2Lekshmi Raghu Nath,Lekshmi Raghu Nath2,5Mullan Vellandy Reshma,Mullan Vellandy Reshma6,7Sankar SundaramSankar Sundaram8Nikhil Ponnoor AntoNikhil Ponnoor Anto4Ravi Shankar Lankalapalli,*Ravi Shankar Lankalapalli3,7*Ruby John Anto*Ruby John Anto2*Smitha Vadakkeveettil Bava*Smitha Vadakkeveettil Bava1*
  • 1Department of Biotechnology, University of Calicut, Malappuram, India
  • 2Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India
  • 3Chemical Sciences and Technology Division, Council for Scientific and Industrial Research (CSIR)-National Institute for Interdisciplinary Science and Technology (CSIR-NIIST), Thiruvananthapuram, India
  • 4The Shraga Segal Department of Microbiology-Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
  • 5Department of Pharmacognosy, Amritha School of Pharmacy, Amritha Vishwa Vidyapeetham, Amrita Institute of Medical Sciences (AIMS) Health Science Campus, Ponekkara P.O, Kochi, India
  • 6Agro-Processing and Technology Division, Council for Scientific and Industrial Research (CSIR)-National Institute for Interdisciplinary Science and Technology (CSIR-NIIST), Thiruvananthapuram, India
  • 7Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India
  • 8Department of Pathology, Government Medical College, Kottayam, India

A Corrigendum on:
Cucurbitacin B, purified and characterized from the rhizome of Corallocarpus epigaeus exhibits anti-melanoma potential

By Aiswarya SUD, Vikas G, Haritha NH, Liju VB, Shabna A, Swetha M, Rayginia TP, Keerthana CK, Nath LR, Reshma MV, Sundaram S, Anto NP, Lankalapalli RS, Anto RJ and Bava SV (2022). 12:903832. doi: 10.3389/fonc.2022.903832

In the published article, there was an error in Figure 2 as published. The blot quantification graph of Figure 2C was duplicated in place of the graph for Figure 2D. The corrected Figure 2 appears below.

FIGURE 2
www.frontiersin.org

Figure 2 ECF triggers apoptotic mode of cell death in melanoma (A, B) ECF induces apoptosis in A375 cells as assessed by Annexin/PI staining, and was quantitated by FACS analysis. (C–H) ECF potentiates the activation of caspases and cleavage of PARP in A375 cells as analyzed by immunoblotting. Data are representative of three independent experiments (Mean ± SEM) and P-values are calculated using one-way ANOVA. ****P ≤ 0.0001, ***P ≤ 0.001, **P ≤ 0.01, *P ≤ 0.1and ns ≥ 0.05.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: corallocarpus epigaeus, cucurbitacin B, melanoma, apoptosis, NMR spectroscopy, mass spectrometry

Citation: Aiswarya SUD, Vikas G, Haritha NH, Liju VB, Shabna A, Swetha M, Rayginia TP, Keerthana CK, Nath LR, Reshma MV, Sundaram S, Anto NP, Lankalapalli RS, Anto RJ and Bava SV (2022) Corrigendum: Cucurbitacin B, purified and characterized from the rhizome of Corallocarpus epigaeus exhibits anti-melanoma potential. Front. Oncol. 12:989283. doi: 10.3389/fonc.2022.989283

Received: 08 July 2022; Accepted: 19 July 2022;
Published: 12 August 2022.

Edited and Reviewed by:

Balaji Krishnamachary, Johns Hopkins University, United States

Copyright © 2022 Aiswarya, Vikas, Haritha, Liju, Shabna, Swetha, Rayginia, Keerthana, Nath, Reshma, Sundaram, Anto, Lankalapalli, Anto and Bava. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ravi Shankar Lankalapalli, ravishankar@niist.res.in; Ruby John Anto, rjanto@rgcb.res.in; Smitha Vadakkeveettil Bava, smithanishad@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.